JPMorgan Chase & Co. has filed a major holdings notification disclosing a reduction in its total voting interest in Bodycote PLC (BOY), the UK-listed specialist heat treatment and thermal processing group. The threshold was crossed on 27 October 2026, with the issuer notified two days later on 29 October 2026. JPMorgan's combined position — comprising direct shares and financial instruments — fell from 10.987604% to 9.609260%, dropping the US banking giant's total notified stake to below the 11% level previously reported. Investors in Bodycote may wish to monitor whether further adjustments to this position follow.

Key Points

  • Bodycote PLC (BOY) — UK-listed specialist in heat treatment and thermal processing services
  • JPMorgan Chase & Co. filed a TR-1 major holdings notification disclosing a net reduction in its combined voting interest in Bodycote
  • Total combined position moved from 10.987604% to 9.609260%, representing 16,353,804 voting rights as at 27 October 2026
  • Investors should watch whether JPMorgan's direct shareholding or swap portfolio shifts further in subsequent notifications

JPMorgan's Direct Shareholding in Bodycote Falls to 1.22%

According to the TR-1 disclosure, JPMorgan Chase & Co.'s voting rights attached directly to Bodycote shares — held indirectly through J.P. Morgan Securities PLC — stood at 2,082,858 shares, equating to 1.223857% of voting rights as at 27 October 2026. This compares with a previously notified direct voting rights figure of 2.616185%, indicating a reduction in the physical shareholding component of JPMorgan's overall position in the FTSE-listed industrial services company, which provides heat treatment, hot isostatic pressing, and surface technology services to industries including aerospace, automotive, and energy globally.

Cash-Settled Equity Swaps Account for 8.39% of Bodycote Voting Exposure

The bulk of JPMorgan's remaining economic exposure to Bodycote is held through a portfolio of cash-settled equity swaps, totalling 14,270,946 voting rights and representing 8.385403% of the company's voting rights. These instruments, disclosed under DTR5.3.1R.(1)(b), carry expiration dates ranging from October 2026 through to November 2029 and are settled in cash rather than through physical delivery of shares. The previous notification recorded a comparable 8.371419% through financial instruments, suggesting the swap book has remained broadly stable while the direct share position has been reduced.

Controlled Undertakings Chain Links JPMorgan Chase to Three UK Entities

The notification sets out a full chain of controlled undertakings through which the interests are held. J.P. Morgan Securities PLC holds the financial instrument exposure of 8.385403%, giving it a total notified position of 9.313477% when combined with direct holdings. Two further entities — J.P. Morgan SE and J.P. Morgan Markets Limited — are also listed within the chain, with JPMorgan Chase & Co. identified as the ultimate controlling entity across all three ownership structures. The disclosure was completed in London on 29 October 2026, in accordance with UK DTR requirements.

What the Bodycote Stake Change Means for Major Shareholder Transparency

Under the Financial Conduct Authority's Disclosure and Transparency Rules, institutional investors must notify issuers when their combined voting interest crosses designated thresholds. JPMorgan's total position of 9.609260% remains substantial relative to Bodycote's overall shareholder base, and the disclosure confirms the US financial group retains a significant economic interest in the company through its swap portfolio. Bodycote operates heat treatment facilities across Europe, North America, and Asia, and its shareholder register is closely watched by investors tracking institutional sentiment toward the specialist industrial services sector.